<DOC>
	<DOC>NCT02571699</DOC>
	<brief_summary>The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block.</brief_summary>
	<brief_title>Minimum Effective Volume of Lidocaine-Bupivacaine for Subgluteal Block</brief_title>
	<detailed_description>The aim of this study is to determine the minimum effective volume of LA in 90 % of patients (MEV90) required for US-guided subgluteal sciatic nerve block. Success rate is defined as a minimal composite score of 6 points (out of 8 points) at 30 minutes.</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>age between 18 and 75 years American Society of Anesthesiologists classification 13 body mass index between 20 and 35 adults who are unable to give their own consent preexisting neuropathy (assessed by history and physical examination) coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets≤ 100, International Normalized Ratio≥ 1.4 or partial prothrombin time ≥ 50) renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100) hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100) allergy to LA pregnancy prior surgery in the subgluteal region chronic pain syndromes requiring opioid intake at home</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>